Jia-Shiun Leu1, Mei-Ling Chen2, So-Yi Chang3, Sung-Liang Yu4, Chia-Wei Lin3, Hsuan Wang3, Wan-Chen Chen3, Chin-Hao Chang5, Jann-Yuan Wang6, Li-Na Lee7, Chong-Jen Yu6, Igor Kramnik8, Bo-Shiun Yan3. 1. 1 Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan. 2. 2 Graduate Institute of Oncology. 3. 3 Institute of Biochemistry and Molecular Biology, and. 4. 4 Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University Medical College, Taipei, Taiwan. 5. 5 Department of Medical Research. 6. 6 Department of Internal Medicine, and. 7. 7 Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan; and. 8. 8 Pulmonary Center, Department of Medicine, National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts.
Abstract
RATIONALE: How host genetic factors affect Mycobacterium tuberculosis (Mtb) infection outcomes remains largely unknown. SP110b, an IFN-induced nuclear protein, is the nearest human homologue to the mouse Ipr1 protein that has been shown to control host innate immunity to Mtb infection. However, the function(s) of SP110b remains unclear. OBJECTIVES: To elucidate the role of SP110b in controlling host immunity and susceptibility to tuberculosis (TB), as well as to identify the fundamental immunological and molecular mechanisms affected by SP110b. METHODS: Using cell-based approaches and mouse models of Mtb infection, we characterized the function(s) of SP110b/Ipr1. We also performed genetic characterization of patients with TB to investigate the role of SP110 in controlling host susceptibility to TB. MEASUREMENTS AND MAIN RESULTS: SP110b modulates nuclear factor-κB (NF-κB) activity, resulting in downregulation of tumor necrosis factor-α (TNF-α) production and concomitant upregulation of NF-κB-induced antiapoptotic gene expression, thereby suppressing IFN-γ-mediated monocyte and/or macrophage cell death. After Mtb infection, TNF-α is also downregulated in Ipr1-expressing mice that have alleviated cell death, less severe necrotic lung lesions, more efficient Mtb growth control in the lungs, and longer survival. Moreover, genetic studies in patients suggest that SP110 plays a key role in modulating TB susceptibility in concert with NFκB1 and TNFα genes. CONCLUSIONS: These results indicate that SP110b plays a crucial role in shaping the inflammatory milieu that supports host protection during infection by fine-tuning NF-κB activity, suggesting that SP110b may serve as a potential target for host-directed therapy aimed at manipulating host immunity against TB.
RATIONALE: How host genetic factors affect Mycobacterium tuberculosis (Mtb) infection outcomes remains largely unknown. SP110b, an IFN-induced nuclear protein, is the nearest human homologue to the mouseIpr1 protein that has been shown to control host innate immunity to Mtb infection. However, the function(s) of SP110b remains unclear. OBJECTIVES: To elucidate the role of SP110b in controlling host immunity and susceptibility to tuberculosis (TB), as well as to identify the fundamental immunological and molecular mechanisms affected by SP110b. METHODS: Using cell-based approaches and mouse models of Mtb infection, we characterized the function(s) of SP110b/Ipr1. We also performed genetic characterization of patients with TB to investigate the role of SP110 in controlling host susceptibility to TB. MEASUREMENTS AND MAIN RESULTS: SP110b modulates nuclear factor-κB (NF-κB) activity, resulting in downregulation of tumor necrosis factor-α (TNF-α) production and concomitant upregulation of NF-κB-induced antiapoptotic gene expression, thereby suppressing IFN-γ-mediated monocyte and/or macrophage cell death. After Mtb infection, TNF-α is also downregulated in Ipr1-expressing mice that have alleviated cell death, less severe necrotic lung lesions, more efficient Mtb growth control in the lungs, and longer survival. Moreover, genetic studies in patients suggest that SP110 plays a key role in modulating TB susceptibility in concert with NFκB1 and TNFα genes. CONCLUSIONS: These results indicate that SP110b plays a crucial role in shaping the inflammatory milieu that supports host protection during infection by fine-tuning NF-κB activity, suggesting that SP110b may serve as a potential target for host-directed therapy aimed at manipulating host immunity against TB.
Authors: K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins Journal: Mol Cell Biol Date: 1999-09 Impact factor: 4.272
Authors: Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik Journal: Nature Date: 2005-04-07 Impact factor: 49.962
Authors: Tony Roscioli; Simon T Cliffe; Donald B Bloch; Christopher G Bell; Glenda Mullan; Peter J Taylor; Maria Sarris; Joanne Wang; Jennifer A Donald; Edwin P Kirk; John B Ziegler; Ulrich Salzer; George B McDonald; Melanie Wong; Robert Lindeman; Michael F Buckley Journal: Nat Genet Date: 2006-04-30 Impact factor: 38.330
Authors: Jeffrey S Szeszko; Barry Healy; Helen Stevens; Yanina Balabanova; Francis Drobniewski; John A Todd; Sergey Nejentsev Journal: Hum Genet Date: 2006-12-06 Impact factor: 4.132
Authors: Lianghua Bin; Claire Malley; Patricia Taylor; Meher Preethi Boorgula; Sameer Chavan; Michelle Daya; Malaika Mathias; Gautam Shankar; Nicholas Rafaels; Candelaria Vergara; Joseph Potee; Monica Campbell; Jon M Hanifin; Eric Simpson; Lynda C Schneider; Richard L Gallo; Tissa Hata; Amy S Paller; Anna De Benedetto; Lisa A Beck; Peck Y Ong; Emma Guttman-Yassky; Brittany Richers; David Baraghoshi; Ingo Ruczinski; Kathleen C Barnes; Donald Y M Leung; Rasika A Mathias Journal: Allergy Date: 2021-03-15 Impact factor: 13.146
Authors: Daisy X Ji; Livia H Yamashiro; Katherine J Chen; Naofumi Mukaida; Igor Kramnik; K Heran Darwin; Russell E Vance Journal: Nat Microbiol Date: 2019-10-14 Impact factor: 17.745